ANI Pharmaceuticals Inc [ANIP] stock prices are up 10.58% to $84.35 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ANIP shares have gain 7.23% over the last week, with a monthly amount glided 2.83%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ANI Pharmaceuticals Inc [NASDAQ: ANIP] stock has seen the most recent analyst activity on July 10, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $84. Previously, Jefferies started tracking the stock with Buy rating on March 14, 2025, and set its price target to $80. On March 12, 2025, JP Morgan initiated with an Overweight rating and assigned a price target of $85 on the stock. Leerink Partners started tracking the stock assigning an Outperform rating and suggested a price target of $80 on December 11, 2024. Piper Sandler initiated its recommendation with an Overweight and recommended $68 as its price target on October 11, 2024. CapitalOne started tracking with an Overweight rating for this stock on March 15, 2024, and assigned it a price target of $80. In a note dated August 22, 2023, H.C. Wainwright reiterated a Buy rating on this stock and boosted its target price from $60 to $73.
The stock price of ANI Pharmaceuticals Inc [ANIP] has been fluctuating between $52.74 and $99.50 over the past year. Currently, Wall Street analysts expect the stock to reach $104.75 within the next 12 months. ANI Pharmaceuticals Inc [NASDAQ: ANIP] shares were valued at $84.35 at the most recent close of the market. An investor can expect a potential return of 24.18% based on the average ANIP price forecast.
Analyzing the ANIP fundamentals
The ANI Pharmaceuticals Inc [NASDAQ:ANIP] reported sales of 826.88M for trailing twelve months, representing a surge of 53.58%. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.07%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.08 and Total Capital is 0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.64.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that ANI Pharmaceuticals Inc [NASDAQ:ANIP]’s Current Ratio is 2.58. In addition, the Quick Ratio stands at 2.04 and the Cash Ratio stands at 0.97. Considering the valuation of this stock, the price to sales ratio is 2.29, the price to book ratio is 3.75 and price to earnings (TTM) ratio is 51.73.
Transactions by insiders
Recent insider trading involved Davis Krista, SVP, CHIEF HR OFFICER, that happened on Dec 18 ’25 when 1622.0 shares were sold. SR. VP, GENERAL COUNSEL & SEC., Cook Meredith completed a deal on Dec 12 ’25 to sell 400.0 shares. Meanwhile, Director TANNENBAUM RENEE P sold 1800.0 shares on Dec 05 ’25.
